Transverse Medical Inc.

About Transverse Medical Inc.

Transverse Medical Inc. is a medical device company focused on developing the POINT-GUARD™ Cerebral Embolic Protection device to address the unmet need for full-brain protection and eliminate periprocedural stroke and silent stroke during structural heart procedures, such as Transcatheter Aortic Valve Replacement (TAVR). Their mission is to reduce and eliminate the risk of procedural stroke during cardiovascular procedures by providing maximum coverage and complete cerebral embolic protection, while their vision is to ensure heart procedures are performed without the risk of stroke or unnecessary complications.

Products & Services

POINT-GUARD™ Cerebral Embolic Protection:A device designed to provide full-brain protection by minimizing or eliminating the risk of stroke during cardiovascular procedures through maximum coverage and filtering of cerebral embolic debris. It is currently an investigational device, not cleared for sale by any regulatory authority.

Specialties

Cerebral Embolic Protection Stroke Prevention Structural Heart Procedures Transcatheter Aortic Valve Replacement (TAVR)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B2 T: - FT: Series B2	A: 10000000 MR: - FA: over $10 million FAN: 10000000	D: 2025-04-28 FD: 2025-04-28	1 investors

Series B2 Latest

2025-04-28

$10.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Stanley Lapidus

Executive & Board

LinkedIn (Pro only)

T

Thomas Engels

Clinical Affairs

LinkedIn (Pro only)

Z

Zachary Woodson

Regulatory Affairs

LinkedIn (Pro only)

A

Abe Zandi

Technology Advisor

L

Larry Blankenship

Technology Officer

S

Samir Kapadia

Chairman, Cardiovascular Medicine

View 23 more team members with Pro

Unlock Full Team Directory

Recent News